市場調査レポート
商品コード
1439364
耳鼻咽喉科ハンドヘルド器具 - 世界市場の考察、競合情勢、市場予測(2030年)ENT Handheld Instruments - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
耳鼻咽喉科ハンドヘルド器具 - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の耳鼻咽喉科ハンドヘルド器具の市場規模は、2024年~2030年の予測期間にCAGRで6.36%の成長が見込まれます。耳鼻咽喉科ハンドヘルド器具の需要は主に、難聴の有病率の増加、甲状腺がんの有病率の増加、副鼻腔炎の患者の増加、老年人口の増加によって後押しされており、これらすべてが2024年~2030年の予測期間に耳鼻咽喉科ハンドヘルド器具市場の成長に寄与します。
耳鼻咽喉科ハンドヘルド器具の市場力学
耳鼻咽喉科ハンドヘルド器具市場はさまざまな要因によって製品需要が伸びており、その1つがさまざまな原因による難聴患者の増加です。世界保健機関(WHO)の最新のデータによると、2022年4月現在、約4億3,000万人がさまざまな程度の難聴に苦しんでいます。このファクトシートはさらに、2050年までに約25億人が何らかの難聴に罹患すると推定しています。鼓膜修復術(鼓膜形成術)、鼓膜チューブ留置術、鼓膜摘出術などの耳の手術は、耳鼻咽喉科で行われる一般的な手術の一部であり、耳鼻咽喉科ハンドヘルド器具が広く使用されています。したがって、難聴の有病率の増加は、患者の聴力を回復するために行われるこのような処置の件数の増加をもたらし、ひいては2024年~2030年の予測期間に世界の耳鼻咽喉科ハンドヘルド器具市場の成長を促進します。
世界の耳鼻咽喉科ハンドヘルド器具市場の成長に寄与するもう1つの主な要因は、甲状腺がんの有病率の増加です。GLOBOCANの2020年のデータによると、2020年に世界中で約58万6,202人の甲状腺がん患者が新たに診断されました。甲状腺がんの治療法の1つは甲状腺切除術で、甲状腺の一部または全部を切除します。これは、手術中に使用されるさまざまな耳鼻咽喉科ハンドヘルド器具の助けを借りて行われます。したがって、甲状腺がんの有病率の増加は、甲状腺切除術の実施件数の増加をもたらし、最終的に予測期間中の耳鼻咽喉科ハンドヘルド器具市場の成長に寄与します。
しかし、新興経済国では耳鼻咽喉科疾患や治療に関する認知度が低いことや、耳鼻咽喉科ハンドヘルド手術器具の滅菌に対する一定の要件が、耳鼻咽喉科ハンドヘルド器具市場の成長抑制要因となる可能性があります。
前述の要因に加え、耳鼻咽喉科ハンドヘルド器具市場は、COVID-19の蔓延を抑えるために必要な措置としてロックダウンが課されたため、一時的に後退した時期がありました。この間の主な措置の1つは、多数の選択的処置と外来受診の停止でした。この措置により、耳鼻咽喉科に関連するさまざまな処置がロックダウン初期には必要不可欠でないとみなされたため、市場における耳鼻咽喉科ハンドヘルド器具の需要が減少し、それによって市場の成長が短期間制限されました。とはいえ、耳鼻咽喉科ハンドヘルド器具市場は、世界中で多数のCOVID-19ワクチンが承認および投与されたことにより、医療サービスを含むさまざまな領域で活動が再開され、回復期に入っています。
耳鼻咽喉科ハンドヘルド器具市場のセグメント分析
耳鼻咽喉科ハンドヘルド器具市場の製品セグメントでは、耳科器具カテゴリが予測期間に大きなシェアを占めると予測されています。これは、高齢者の加齢に伴う難聴、特に小児における中耳炎、めまいや立ちくらみの症例、耳鳴りなど、耳に関連する疾患の有病率が、鼻科や喉頭科に関連する適応症に比べて上昇しているためと考えられます。したがって、耳に関連する疾患の有病率の増加が耳科関連ハンドヘルド器具の需要を促進し、その結果、予測期間(2024年~2030年)に耳鼻咽喉科ハンドヘルド器具市場全体が成長する可能性があります。
北米が耳鼻咽喉科ハンドヘルド器具市場全体を独占すると予測されます。
すべての地域の中で、北米が耳鼻咽喉科ハンドヘルド器具市場で最大のシェアを占めると予測されます。閉塞性睡眠時無呼吸症候群の急増、副鼻腔炎の有病率の増加、老年人口の増加、難聴の有病率や治療に関する意識を高める政府の取り組みの高まりといった重要な成長要因が、北米の耳鼻咽喉科ハンドヘルド器具市場の成長を後押しすると予測されています。さらに、高い可処分所得、精巧な医療インフラ、新製品の承認、認知度の向上も、この地域の市場成長を後押ししています。
当レポートでは、世界の耳鼻咽喉科ハンドヘルド器具市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
ENT Handheld Instruments Market By Product Type (Otology Instruments, Rhinology Instruments, And Laryngeal Instruments), By End User (Hospitals, Specialty Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increase in surgeries due to rise in prevalence of ENT disorders such as hearing loss and thryoid cancer.
Global ENT Handheld Instruments Market is expected to grow at a CAGR of 6.36% during the forecast period from 2024 to 2030. The demand for ENT handheld instruments is primarily being boosted by increasing prevalence of hearing loss, increasing prevalence of thyroid cancer, rising number of cases of sinusitis, and rising geriatric population, all these collectively contributing in the growth of the ENT handheld instruments market during the forecast period from 2024-2030.
ENT Handheld Instruments Market Dynamics:
The ENT handheld instruments market is witnessing a growth in product demand owing to numerous factors, one of them being the increasing number of cases of hearing loss due to different causes. As per the latest data provided by the World Health Organization, as of April 2022, near about 430 million people suffer from varying degrees of hearing loss. The factsheet further stated that by 2050, approximately 2.5 billion people are estimated to be affected with some degree of hearing loss. Ear surgeries such as eardrum repair (tympanoplasty), ear tube placement, and stapedectomy are some of the common procedures conducted in the ENT specialty for which ENT handheld instruments are extensively used. Therefore, the rising prevalence of hearing loss would result in the increase in the volume of such procedures, which being performed to restore hearing capacity in patients, which in turn driving the global ENT handheld instruments market growth during the forecast period from 2024-2030.
Another key factor contributing in the growth of the global ENT handheld instruments market is the rising prevalence of thyroid cancer. As per the GLOBOCAN 2020 data, in 2020, nearly 586,202 new cases of thyroid cancer were diagnosed across the globe. One of the treatment methods for thyroid cancer is thyroidectomy in which the thyroid gland is either partially or fully removed. This is done with the help of various ENT handheld instruments that are employed during the procedure. Thus, the increase in the prevalence of thyroid cancer would result in the increase in the number of thryoidectomies being performed, eventually contributing in the growth of the ENT handheld instruments market during the forecast period.
However, limited awareness regarding ENT disorders and treatments in emerging economies and the constant need for sterilizing the ENT handheld surgical instruments may be certain impeding factors to ENT handheld instruments market growth.
In addition to the previously mentioned factors, the ENT handheld instruments market witnessed a period of temporary setback due to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for ENT handheld instruments in the market as various procedures pertaining to ENT specialty were deemed non-essential during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for ENT handheld instruments is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the ENT handheld instruments market during the forecast period
ENT Handheld Instruments Market Segment Analysis:
ENT Handheld Instruments Market by Product Type (Otology Instruments, Rhinology Instruments, and Laryngeal Instruments), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the product segment of the ENT Handheld Instruments Market, the otology instruments category is estimated to hold a significant share in the forecast period. This can be ascribed to the rising prevalence of ear-related ailments such as age- related hearing loss in elderly, otitis media particularly in pediatric population, cases of vertigo and dizziness, and tinnitus among others compared to indications associated with rhinology and laryngology. Therefore, the increase in the prevalence of ear-related ailments are expected to drive the demand for otology-related handheld devices, which in turn would result in the growth of the overall the ENT handheld instruments market during the forecast period (2024-2030).
North America is expected to dominate the Overall ENT Handheld Instruments Market:
Among all the regions, North America is expected to account for the largest share in the ENT handheld instruments market. Owing to significant growth factors such as surging cases of obstructive sleep apnea, increasing prevalence of sinusitis, increasing geriatric population, and rising government initiatives for creating awareness regarding hearing loss prevalence and treatment are expected to aid in the growth of the North America ENT Handheld Instruments Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.
As per the data provided by the Centers for Disease Control and Prevention (CDC) in 2020, near about 28.9 million adults were diagnosed with sinusitis in the United States. Moreover, the information provided by the World Allergy Organization (2023), the prevalence of chronic sinusitis is usually in the range of 12% in the United States. Chronic sinusitis can cause major trouble in breathing and sinus surgery is often recommended in patients that are refractory to medications and other therapies. Therefore, with the presence of high patient pool of chronic sinusitis patients in the country, it is estimated that there may be an increase in the number of procedures of sinus surgery being performed that may in turn drive the demand for ENT handheld instruments, thereby supporting the growth of the United States ENT handheld instruments market during the forecast period.
Furthermore, according to the American Sleep Apnea Association (2023), currently an estimated number of 22 million Americans suffer from obstructive sleep apnea. Even though positive airway pressure (PAP) therapy is the gold standard OSA treatment, it has been observed that the patient compliance with PAP therapy can be low due to various factors as well as PAP therapy being ineffective in other set of patients. Therefore, in such patients, surgeries are recommended which are focused on correcting the structural defects in the nose, throat, and upper respiratory tract. Thus, owing to the increasing prevalence of OSA in the country, the demand for ENT handheld instruments may witness an increase in the United States, resulting in the growth of the United States ENT handheld instruments market as well as the North America ENT handheld instruments market.
ENT Handheld Instruments Market Key Players:
Some of the key market players operating in the ENT handheld instruments market includes Integra Lifesciences, Stryker, Medtronic, SPIGGLE & THEIS Medizintechnik GmbH, Olympus, PRO-MED Instrumente GmbH, B. Braun Melsungen AG, Grace Medical, Heinz Kurz GmbH, Summit Medical LLC, Advin Healthcare, FENTEX medical GmbH., Rica Surgical Products, Inc., BLINK MEDICAL, Symmetry Surgical Inc., Bailey Instruments Ltd, Tonglu WANHE Medical Instrument Co.,Ltd, Moonlight Surgical Works, SOLCO BIOMEDICAL CO., LTD, ELMED Incorporated, BD, Teleflex Incorporated and others.
Recent Developmental Activities in ENT Handheld Instruments Market:
In August 2022, Medtronic announced the acquisition of a company with an extensive ENT portfolio- Intersect ENT for approximately USD 1.1 billion.
In May 2020, Stryker announced the acquisition of Entellus Medical Inc in order to include the XpRESS products to their ENT product offerings.
In February 2019, Stryker announced the acquisition of Arrinex Inc thereby enabling Stryker to include the Clarifix device to their ENT product portfolio.
Key Takeaways from the ENT Handheld Instruments Market Report Study
Market size analysis for current ENT handheld instruments market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ENT handheld instruments market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global ENT Handheld Instruments Market.
Various opportunities available for the other competitor in the ENT Handheld Instruments Market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current ENT handheld instruments market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for ENT handheld instruments market growth in the coming future?
Target Audience who can be benefited from this ENT Handheld Instruments Market Report Study
ENT Handheld Instruments products providers
Research organizations and consulting companies
ENT Handheld Instruments-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in ENT handheld instruments
Various End-users who want to know more about the ENT Handheld Instruments market and latest technological developments in the ENT Handheld Instruments market.
Frequently Asked Questions for ENT Handheld Instruments Market:
An ENT handheld instrument is a device which are majorly employed during various ENT surgeries and specialized according to the structure being operated on such as otology-handheld instruments, rhinology instruments, and others.
Global ENT Handheld Instruments Market is expected to grow at a CAGR of 6.36% during the forecast period from 2024-2030.
The demand for ENT handheld instruments is primarily being boosted by increasing prevalence of hearing loss, increasing prevalence of thyroid cancer, rising number of cases of sinusitis, and rising geriatric population thereby contributing in the growth of the ENT handheld instruments market in the forecast period.
Some of the key market players operating in the ENT handheld instruments market includes Integra Lifesciences, Stryker, Medtronic, SPIGGLE & THEIS Medizintechnik GmbH, Olympus, PRO-MED Instrumente GmbH, B. Braun Melsungen AG, Grace Medical, Heinz Kurz GmbH, Summit Medical LLC, Advin Healthcare, FENTEX medical GmbH., Rica Surgical Products, Inc., BLINK MEDICAL, Symmetry Surgical Inc., Bailey Instruments Ltd, Tonglu WANHE Medical Instrument Co.,Ltd, Moonlight Surgical Works, SOLCO BIOMEDICAL CO., LTD, ELMED Incorporated, BD, Teleflex Incorporated and others.
North America is expected to dominate the overall ENT Handheld Instruments market during the forecast period, 2024-2030. Owing to significant growth factors such as surging cases of obstructive sleep apnea, increasing prevalence of sinusitis, increasing geriatric population, and rising government initiatives for creating awareness regarding hearing loss prevalence and treatment are expected to aid in the growth of the North America ENT Handheld Instruments Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.